Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma

Condition:   Lymphoma, B-Cell Intervention:   Biological: TAC01-CD19 Sponsor:   Triumvira Immunologics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials